The New Postpartum Depression Pill Is Not a Panacea

(MedPage Today) — Following the FDA approval of the drug zuranolone (Zurzuvae) for treating postpartum depression (PPD), I analyzed some of the clinical trial data through a biopsychosocial and intersectionality lens. From a scientific, social…

Powered by WPeMatico